Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other financing activities (2016 - 2025)

Historic Other financing activities for Gyre Therapeutics (GYRE) over the last 8 years, with Q3 2025 value amounting to -$315000.0.

  • Gyre Therapeutics' Other financing activities fell 73000.0% to -$315000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 7565.65%. This contributed to the annual value of $536000.0 for FY2024, which is N/A changed from last year.
  • Per Gyre Therapeutics' latest filing, its Other financing activities stood at -$315000.0 for Q3 2025, which was down 73000.0% from $1.7 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Other financing activities high stood at $1.7 million for Q2 2025, and its period low was -$315000.0 during Q3 2025.